Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
Unité tumorigenèse et résistance aux traitements, Institut Pasteur de Lille, F-59000 Lille, France.
Nucleic Acids Res. 2021 Nov 8;49(19):11022-11037. doi: 10.1093/nar/gkab882.
Nonsense-mediated mRNA decay (NMD) is a highly regulated quality control mechanism through which mRNAs harboring a premature termination codon are degraded. It is also a regulatory pathway for some genes. This mechanism is subject to various levels of regulation, including phosphorylation. To date only one kinase, SMG1, has been described to participate in NMD, by targeting the central NMD factor UPF1. Here, screening of a kinase inhibitor library revealed as putative NMD inhibitors several molecules targeting the protein kinase AKT1. We present evidence demonstrating that AKT1, a central player in the PI3K/AKT/mTOR signaling pathway, plays an essential role in NMD, being recruited by the UPF3X protein to phosphorylate UPF1. As AKT1 is often overactivated in cancer cells and as this should result in increased NMD efficiency, the possibility that this increase might affect cancer processes and be targeted in cancer therapy is discussed.
无意义介导的 mRNA 降解(NMD)是一种高度调控的质量控制机制,通过该机制可降解含有提前终止密码子的 mRNA。它也是一些基因的调控途径。该机制受到多种水平的调控,包括磷酸化。迄今为止,只有一种激酶,即 SMG1,通过靶向中央 NMD 因子 UPF1 参与 NMD。在这里,激酶抑制剂文库的筛选显示了几种针对蛋白激酶 AKT1 的潜在 NMD 抑制剂。我们提供的证据表明,AKT1 是 PI3K/AKT/mTOR 信号通路的核心成员,在 NMD 中发挥重要作用,它被 UPF3X 蛋白募集来磷酸化 UPF1。由于 AKT1 在癌细胞中经常过度激活,并且这应该导致 NMD 效率增加,因此讨论了这种增加是否可能影响癌症过程并成为癌症治疗的靶点。